TPST
Tempest Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.75 / 10
Netural
Fund flow metrics are encouraging at 7.5/10, with Medium trends showing positive movement despite negative overall, block, Small, Large, and Extra-large signals. Analyst sentiment is overwhelmingly bullish (Strong Buy at 100% coverage), yet historical win rates are low (0.0%), tempering conviction. This mix of robust fund inflows and strong but unproven analyst calls offers a silver lining but not enough to offset weaker fundamentals and technicals.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-22
InstitutionHC Wainwright & Co.
Times predicted3
Historical Win Rate0.0%
What is the analyst consensus for TPST?
- TPST holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.75/10 (Netural).
